HomeCompareHHOLF vs MRK

HHOLF vs MRK: Dividend Comparison 2026

HHOLF yields 4000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HHOLF wins by $7175340620755.81M in total portfolio value
10 years
HHOLF
HHOLF
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full HHOLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HHOLF vs MRK

📍 HHOLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHHOLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HHOLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HHOLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HHOLF
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HHOLF beats the other by $5,813,155,604,218,152,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HHOLF + MRK for your $10,000?

HHOLF: 50%MRK: 50%
100% MRK50/50100% HHOLF
Portfolio after 10yr
$3587670310377.96M
Annual income
$3,419,503,296,598,923,000.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HHOLF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HHOLF buys
0
MRK buys
0
No recent congressional trades found for HHOLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHHOLFMRK
Forward yield4000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7175340620755.87M$56.8K
Annual income after 10y$6,839,006,593,197,835,000.00$9,798.13
Total dividends collected$7152397773804.84M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HHOLF vs MRK ($10,000, DRIP)

YearHHOLF PortfolioHHOLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$410,700$400,000.00$11,206$366.19+$399.5KHHOLF
2$15,792,720$15,353,271.03$12,650$502.35+$15.78MHHOLF
3$568,657,142$551,758,931.89$14,407$694.19+$568.64MHHOLF
4$19,176,207,860$18,567,744,718.20$16,585$967.82+$19176.19MHHOLF
5$605,696,028,890$585,177,486,479.73$19,342$1,363.89+$605696.01MHHOLF
6$17,922,210,653,594$17,274,115,902,681.27$22,913$1,947.19+$17922210.63MHHOLF
7$496,869,793,504,300$477,693,028,104,954.00$27,662$2,823.89+$496869793.48MHHOLF
8$12,908,672,105,251,704$12,377,021,426,202,104.00$34,159$4,173.35+$12908672105.22MHHOLF
9$314,330,866,876,668,540$300,518,587,724,049,200.00$43,337$6,308.80+$314330866876.63MHHOLF
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$56,776$9,798.13+$7175340620755.81MHHOLF

HHOLF vs MRK: Complete Analysis 2026

HHOLFStock

Herald Holdings Limited, together with its subsidiaries, engages in the manufacture, sale, and distribution of toys, computer products, housewares, clocks, watches, and electronic and gift products. It offers a range of toys, including action figures, electronic radio-controlled toy cars and boats, electronic games, and pre-school toys; battery-operated and electronic toys, games, radio-controlled vehicles, transformers, and model kits and gift items. The company provides computer products, including magnetic tape head, thin-film tape heads, and motor actuator assemblies, as well as smart connected devices for Internet of Things comprising smart watches, thermostats, sensory array gateways, and remote environmental sensors; and manufactures and sells watches under the Braun, Vivienne Westwood, and Lambretta brands. In addition, it is involved in the property investment and leasing activities; provision of marketing services; and debt and equity securities, and managed funds investment activities, as well as sells and distributes clocks, watches, and electronic products. Herald Holdings Limited operates in Hong Kong, North America, the United Kingdom, rest of Europe, Asia, Mainland China, and internationally. The company was incorporated in 1992 and is headquartered in Hong Kong, Hong Kong.

Full HHOLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HHOLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HHOLF vs SCHDHHOLF vs JEPIHHOLF vs OHHOLF vs KOHHOLF vs MAINHHOLF vs JNJHHOLF vs ABBVHHOLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.